EZH2 and glioblastoma: EZH2 also contributes to the immunosuppressive microenvironment of GBM by triggering specific cytokine expression, maintaining expression of interferon-stimulated genes that promote a M2 microglial phenotype in an iNOS and TGF-β2-dependent manner.